Valeant Eyeing Dermatology, Dentistry for M&A: CEO

March 19 (Bloomberg) -- Mike Pearson, chief executive officer of Valeant Pharmaceuticals International Inc., talks about the company's acquisition and growth strategy. He speaks with Stephanie Ruhle and Matt Miller on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Hong Kong Tycoon Says Property Rebound Could Last Years
39:49 - Hong Kong’s richest man signaled that the property rebound that’s been pushing up prices in the world’s most expensive housing market could persist for as long as two years as growing demand outweighs government curbs. Bloomberg's Prudence Ho reports on "Bloomberg Markets." (Source: Bloomberg)
  • How Fintech Is Changing Business
  • Prestige's Schenker Sees Tire Use and Demand Rising
  • Professor Sees Misallocation of Chinese Investment